To address this objective, women with a BRCA1 or BRCA2 mutation, and with no personal history of cancer, were asked if they would choose their original treatment option (if they had the choice to make again) or other options, including a hypothetical chemoprevention option. This evidence concerns the gene BRCA1 and cancer.